Treatment Action Group, 90 Broad Street, Suite 2503, New York, NY 10004, USA.
VOCAL-NY, 80-A Fourth Avenue, Brooklyn, NY 11217, USA.
Harm Reduction Coalition, 22 West 27th Street, 5th Floor, New York, NY 10001, USA.
Housing Works, 57 Willoughby Street, 2nd Floor, Brooklyn, NY 11201, USA.
San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA.
Project Inform, 273 Ninth Street, San Francisco, CA 94103, USA.
Facente Consulting, 5601 Van Fleet Avenue, Richmond, CA 94804, USA.
Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General, University of California San Francisco, Box 0874, 995 Potrero Avenue, San Francisco, CA 94110, USA.
Center for Health Law and Policy Innovation, Harvard Law School, 122 Boylston Street, Jamaica Plain, MA 02130, USA.
Division of Infectious Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street LMOB Suite GB, Boston, MA 02215, USA. Electronic address: email@example.com.
The United States has national plans for the elimination of hepatitis C virus but much of US health care is organized on the state level and requires local solutions. This article describes the plans developed by New York, Massachusetts, and the city/county of San Francisco for hepatitis C virus elimination. Coalitions capitalize on existing resources and advocate for new resources to address barriers in hepatitis C virus care. Although each coalition has distinct plans, all share a commitment to groups that are disproportionately affected and are at risk for being excluded from advances in hepatitis C virus treatment and cure.